Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 04 2022
Historique:
received: 29 11 2021
accepted: 28 03 2022
entrez: 6 4 2022
pubmed: 7 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

Several studies have found an association of COVID-19 disease severity with Vitamin D deficiency and higher levels of anti-SARS-CoV-2 IgGs. The aim of this study was to determine whether levels of Vitamin D and "inflammatory state" influence the magnitude of anti-SARS-CoV-2 IgGs levels in COVID-19 patients. For this purpose, in 67 patients levels of anti-SARS-CoV-2 IgG were measured in week 4 whereas in 52 patients levels of Vitamin D were measured in week 1 after symptom onset. We found that low Vitamin D levels were significantly associated with age and disease severity whereas there was a trend without significance, towards negative correlation of Vitamin D with anti-SARS-CoV-2 IgG. Anti-SARS-CoV-2 IgG were significantly higher in older ages, patients with severe disease, diabetes and those who received corticosteroid and antibiotic therapy. There was a positive correlation of anti-SARS-CoV-2 IgG with IL-6, CRP, LDH, ESR and with percentages of granulocytes. In conclusion, Vitamin D and anti-SARS-CoV-2 IgG share common parameters associated with inflammatory state. However, even though Vitamin D protects against severe forms of COVID-19 it could not directly affect anti-SARS-CoV-2 IgG production.

Identifiants

pubmed: 35383273
doi: 10.1038/s41598-022-09785-7
pii: 10.1038/s41598-022-09785-7
pmc: PMC8982653
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0
Vitamin D 1406-16-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5699

Informations de copyright

© 2022. The Author(s).

Références

J Med Virol. 2021 Feb;93(2):733-740
pubmed: 32716073
Am J Hematol. 2020 Jul;95(7):834-847
pubmed: 32282949
Nutrients. 2020 Jul 15;12(7):
pubmed: 32679784
Int J Clin Pract. 2021 Nov;75(11):e14675
pubmed: 34322971
J Infect Chemother. 2021 Jun;27(6):808-813
pubmed: 33531292
Nutrients. 2018 Nov 03;10(11):
pubmed: 30400332
Risk Manag Healthc Policy. 2021 Jan 07;14:31-38
pubmed: 33447107
Arch Gynecol Obstet. 2013 Jul;288(1):207-12
pubmed: 23377179
Eur J Nutr. 2021 Feb;60(1):545-548
pubmed: 32851419
Am J Clin Nutr. 2020 May 1;111(5):1036-1047
pubmed: 32232398
Eur J Clin Nutr. 2020 Jun;74(6):856-859
pubmed: 32398871
N Engl J Med. 2020 Sep 10;383(11):1085-1087
pubmed: 32706954
Aging Clin Exp Res. 2020 Jul;32(7):1195-1198
pubmed: 32377965
Nat Commun. 2020 Nov 27;11(1):6044
pubmed: 33247152
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Arch Physiol Biochem. 2023 Feb;129(1):26-32
pubmed: 33125298
Tuberk Toraks. 2020 Sep;68(3):227-235
pubmed: 33295720
Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
PLoS One. 2020 Oct 1;15(10):e0239802
pubmed: 33002041
Sci Transl Med. 2021 Jun 2;13(596):
pubmed: 33979301
Signal Transduct Target Ther. 2021 Mar 8;6(1):113
pubmed: 33686064
Front Immunol. 2020 Dec 09;11:590459
pubmed: 33362771
Sci Rep. 2020 Nov 19;10(1):20191
pubmed: 33214648
J Infect Public Health. 2020 Oct;13(10):1373-1380
pubmed: 32605780
PLoS One. 2020 Sep 17;15(9):e0239252
pubmed: 32941512
Arch Pathol Lab Med. 2020 Dec 1;144(12):1465-1474
pubmed: 32818235
J Endocrinol Invest. 2021 Apr;44(4):765-771
pubmed: 32772324
bioRxiv. 2020 Nov 04;:
pubmed: 33140054
Aging Clin Exp Res. 2020 Oct;32(10):2141-2158
pubmed: 32876941
Cytokine. 2009 Mar;45(3):190-7
pubmed: 19186073
PLoS One. 2014 Mar 25;9(3):e92614
pubmed: 24667823
J Leukoc Biol. 2021 Oct;110(4):809-819
pubmed: 33464639
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Eur Respir J. 2021 Apr 8;57(4):
pubmed: 33303541
PLoS Negl Trop Dis. 2022 Jan 4;16(1):e0010102
pubmed: 34982773
Metabolism. 2014 Aug;63(8):1056-62
pubmed: 24928661
Viruses. 2022 Jan 02;14(1):
pubmed: 35062284
Postgrad Med J. 2021 Jul;97(1149):442-447
pubmed: 32855214
Prostate. 2011 Mar 1;71(4):368-72
pubmed: 20812224
Front Immunol. 2021 Feb 18;12:613422
pubmed: 33679753
Sci China Life Sci. 2021 Mar;64(3):482-485
pubmed: 32876887
Annu Rev Immunol. 2016 May 20;34:335-68
pubmed: 26907215
J Med Virol. 2021 May;93(5):2992-2999
pubmed: 33512007
Br J Haematol. 2020 Aug;190(4):520-524
pubmed: 32531085
Eur J Immunol. 2020 Dec;50(12):2025-2040
pubmed: 33084029
J Med Virol. 2020 Nov;92(11):2409-2411
pubmed: 32516845
Intern Emerg Med. 2013 Feb;8(1):33-40
pubmed: 21437585
medRxiv. 2020 Dec 08;:
pubmed: 33330875
Panminerva Med. 2023 Mar;65(1):23-29
pubmed: 33494567
PLoS One. 2020 Oct 21;15(10):e0241104
pubmed: 33085715
Curr Opin Virol. 2011 Oct;1(4):226-32
pubmed: 22440781
Front Immunol. 2021 Mar 01;12:629193
pubmed: 33732251
Oncologist. 2021 Sep;26(9):e1619-e1632
pubmed: 34018280
J Clin Virol. 2020 Oct;131:104611
pubmed: 32882666
Immunity. 2003 Aug;19(2):225-34
pubmed: 12932356
JAMA Netw Open. 2021 May 3;4(5):e2111634
pubmed: 34009346
Microb Pathog. 2021 Apr;153:104799
pubmed: 33609650
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Infect. 2020 Aug;81(2):e55-e58
pubmed: 32335168
J Clin Lab Anal. 2020 Oct;34(10):e23483
pubmed: 32696465
mSphere. 2020 Jul 15;5(4):
pubmed: 32669467
Immunity. 2020 Jun 16;52(6):971-977.e3
pubmed: 32413330

Auteurs

Hatixhe Latifi-Pupovci (H)

University of Pristina, Georg Bush, No.31, 10000, Prishtina, Kosovo.
University Clinical Center of Kosovo, Pristina, Kosovo.

Sadie Namani (S)

University of Pristina, Georg Bush, No.31, 10000, Prishtina, Kosovo. sadie_namani@yahoo.com.
University Clinical Center of Kosovo, Pristina, Kosovo. sadie_namani@yahoo.com.

Artina Pajaziti (A)

University of Pristina, Georg Bush, No.31, 10000, Prishtina, Kosovo.

Blerina Ahmetaj-Shala (B)

National Heart and Lung Institute, Imperial College London, London, UK.

Lindita Ajazaj (L)

University Clinical Center of Kosovo, Pristina, Kosovo.

Afrim Kotori (A)

University for Business and Technology, Pristina, Kosovo.

Valdete Haxhibeqiri (V)

University Clinical Center of Kosovo, Pristina, Kosovo.

Valentin Gegaj (V)

University Clinical Center of Kosovo, Pristina, Kosovo.

Gramoz Bunjaku (G)

University Clinical Center of Kosovo, Pristina, Kosovo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH